mindsON RBQM | Episode 31: Actioning Risk Signals, determining what is an issue and requirements for follow up

Webinar image

Registration for the webinar

January 15, 2025, 4:00 PM - 5:00 PM
*
*
*
*
*
*
*
By registering, you are submitting your details to the webinar provider and accepting the current privacy policies .
Fields marked with * are mandatory and must be filled in.

The event has already started!

Moderators

Bild eines Moderators

MyRBQM Academy by Cyntegrity

Targeted education helps clinical research teams embrace the implementation process and contribute to its success, ensuring your organization's RBQM strategy has the components it needs to meet regulatory expectations.

Established in 2019, Cyntegrity's MyRBQM® Academy, units first-level online education, comprehensive instructor-led training, and practical case study workshops. Learn more at: www.academy.cyntegrity.com

Bild eines Moderators

Guest Speaker: 

Miguel Valenzuela

Associate Director, 
Clinical Risk & Analytics
(Alnylam Pharmaceuticals)

Miguel has been working in the industry for over 20 years in various capacities in informatics, Clinical Operations, Data Sciences, and Quality Assurance. In his earlier roles at Bayer and Roche, Miguel has led Quality Risk Management, Risk-Based Monitoring, and analytics driven oversight and continuous improvement groups and programs.

Since joining Alnylam in 2019, Miguel, while in GCP Quality Assurance, led the development and implementation of the Risk-Based Quality Management (RBQM+) approach and system in the organization.

Currently, he is the Associate Director Clinical Risk & Analytics, heading up the implementation of the RBQM process and systems and the buildup of the supporting group across Alnylam.

Bild eines Moderators

Dr. Johann Proeve

Chief Scientific Officer (Cyntegrity)

Johann has over 40 years of experience as a biopharmaceutical industry expert, mainly in the former role of VP of Global Clinical Data Management at Bayer Healthcare. Besides being a much sought-after industry speaker, he brings data-driven realism to the table, ensuring that goals are implementable in the real world. Johann has a vast depth of experience in clinical research, which has been invaluable to many.

June 26, 2024 Michal Helbin

A comprehensive approach to the management of risks in a clinical study. The platform is very well designed, it has been very well presented during the webinar. The platform is detailed but graphically appealing. It utilizes the smart risk categories as proposed by the TransCelerate Biopharma, uses some proprietary tools and knowledge as designed by the Cyntegrity and is easily scalable should any organization need to add more categories at any time. Its a product well done.

September 18, 2024 Hanlie Bester

I thoroughly enjoyed the 'mindsON RBQM Episode 27' webinar! Dr. Johann Proeve and Keith Dorricott provided valuable insights on selection of additional risk controls. The examples were well thought out, and I found the integration of LLM responses into the presentation particularly interesting. Looking forward to the next episode!

October 9, 2024 Charlene Dark Dark

The content and the speakers provided informative insights on the important topic of responsible AI implementation in clinical trials. The regulatory and compliance discussions were exceptionally helpful.

Appointments

  • January 15, 2025, 4:00 PM - 5:00 PM

Description

We will highlight the difference between a signal generated by an RBQM system vs an issue. Who should act, how, and on what kind of signal? Which signals can be ignored, which ones may require a follow-up, and which ones need urgent attention since they are not a signal anymore but already an issue? How will any actions and no-action-required decisions be documented for future reference? What should be kept at the end of a study to demonstrate a proper signal and issue management?


ABOUT "mindsON RBQM" WORKSHOPS

The mindsON RBQM workshops provide practical, system-agnostic guidance on the challenges of implementing and executing Risk-Based Quality Management (RBQM) in day-to-day clinical trial operations. These sessions emphasize interactive dialogue and problem-solving, offering a collaborative space to share experiences, explore strategies, and tackle real-world challenges.

Rooted in Quality by Design (QbD) principles, mindsON RBQM focuses on concepts and strategies without being tied to any specific system. For those looking to see these principles applied through technology, the actON QbD series offers complementary workshops with live demonstrations of use cases powered by the MyRBQM Portal.

Whether you choose to participate or simply observe actively, mindsON RBQM provides the knowledge and tools you need to navigate RBQM implementation confidently and effectively.

Place here to upload